APA Alıntı

Kawahara, M., Tada, H., Tokoro, A., Teramukai, S., Origasa, H., Kubota, K., . . . Furuse, K. (2011). Quality-of-life evaluation for advanced non-small-cell lung cancer: A comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01). BioMed Central.

Chicago Stili Alıntı

Kawahara, Masaaki, Harue Tada, Akihiro Tokoro, Satoshi Teramukai, Hideki Origasa, Kaoru Kubota, Tetsu Shinkai, Masanori Fukushima, ve Kiyoyuki Furuse. Quality-of-life Evaluation for Advanced Non-small-cell Lung Cancer: A Comparison between Vinorelbine Plus Gemcitabine Followed By Docetaxel Versus Paclitaxel Plus Carboplatin Regimens in a Randomized Trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01). BioMed Central, 2011.

MLA Alıntı

Kawahara, Masaaki, et al. Quality-of-life Evaluation for Advanced Non-small-cell Lung Cancer: A Comparison between Vinorelbine Plus Gemcitabine Followed By Docetaxel Versus Paclitaxel Plus Carboplatin Regimens in a Randomized Trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01). BioMed Central, 2011.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..